文献速递冠心病

新西兰首次急性冠脉综合征后临床结局的预后建模

Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New Zealand.
PubMed 文献 · Heart · 2023-06-26

中位随访3.5年,20.8%发生死亡/心血管再入院;校正20项临床风险因素后,NT-proBNP和毛利族裔不再显著。

要点

  • 首次ACS后中位3.5年死亡/心血管再入院率达20.8%。
  • NT-proBNP与毛利族裔在简单模型中预测结局,校正临床评分后不显著。
  • 20项临床变量构建的评分可用于首次ACS风险分层。

核心结论

  • 在2015例首次ACS患者中,复发事件常见(20.8%)。
  • NT-proBNP升高和毛利族裔是死亡/心血管再入院的预测因素,但校正20项临床风险因素后不再显著。

研究设计与样本

  • 在2015例MENZACS参与者中计算该评分,并用Cox回归在四个模型中评估NT-proBNP的预后价值。

主要发现

  • 2015例MENZACS参与者平均年龄61岁,79%男性,73%欧洲裔,14%毛利族,5%太平洋岛民;2003例出院时存活。
  • 2003例中416例(20.8%)在中位3.5年内发生全因死亡/心血管再入院。
  • 简单模型中年龄、男性、毛利族裔和NT-proBNP水平是显著预测因素。
  • 校正包含年龄和性别的临床评分后,NT-proBNP不再显著:log2(NT-proBNP) HR 1.03,95%CI 0.98-1.08,p=0.305。
  • 校正后毛利族裔不再显著:HR 1.26,95%CI 0.97-1.62,p=0.084。

临床怎么用

  • 对首次ACS患者可使用基于20项临床变量的评分进行风险分层。
  • NT-proBNP的预后价值在考虑综合临床风险因素后减弱,解读时应结合整体临床评分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Multi-Ethnic New Zealand Study of Acute Coronary Syndromes (MENZACS) was established to investigate the drivers of secondary events after first-time acute coronary syndrome (ACS), including addressing inequitable outcomes by ethnicity. Herein, the first clinical outcomes and prognostic modelling approach are reported. METHODS: First, in 28 176 New Zealanders with first-time ACS from a national registry, a clinical summary score for predicting 1-year death/cardiovascular readmission was created using Cox regression of 20 clinical variables. This score was then calculated in the 2015 participant MENZACS study to represent clinical risk. In MENZACS, Cox regression was used to assess N-terminal pro-B-type natriuretic peptide (NT-proBNP) as a prognostic marker for death/cardiovascular readmission in four models, adjusting for (1) age and sex; (2) age, sex, ethnicity; (3) clinical summary score; (4) clinical summary score and ethnicity. RESULTS: Of the 2015 MENZACS participants (mean age 61 years, 79% male, 73% European, 14% Māori, 5% Pacific people), 2003 were alive at discharge. Of the 2003, 416 (20.8%) experienced all-cause death/cardiovascular readmission over a median of 3.5 years. In a simple model, age, male sex, Māori ethnicity and NT-proBNP levels were significant predictors of outcome. After adjustment for the clinical summary score, which includes age and sex, NT-proBNP and ethnicity were no longer statistically significant: log2(NT-proBNP) hazard ratio (HR) 1.03, 95% confidence interval (95% CI) 0.98 to 1.08, p=0.305; Māori ethnicity HR 1.26, 95% CI 0.97 to 1.62, p=0.084. CONCLUSIONS: In 2015 patients with first-time ACS, recurrent events were common (20.8%). Increasing NT-proBNP levels and Māori ethnicity were predictors of death/cardiovascular readmission, but not after adjustment for the 20 clinical risk factors represented by the clinical summary score. TRIAL REGISTRATION NUMBER: ACTRN12615000676516.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Earle, Poppe, Rolleston, et al. Prognostic modelling of clinical outcomes after first-time acute coronary syndrome in New Zealand. Heart. 2023. PMID: 36787970. doi:10.1136/heartjnl-2022-322010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。